Sonic Healthcare Ltd
ASX:SHL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
24
32.36
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sonic Healthcare Ltd
Sonic Healthcare Ltd
Cost of Revenue
Sonic Healthcare Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Cost of Revenue
-AU$1.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
|
Healthia Ltd
ASX:HLA
|
Cost of Revenue
-AU$20.6m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Cost of Revenue
-AU$22.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Capitol Health Ltd
ASX:CAJ
|
Cost of Revenue
-AU$16m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-16%
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Cost of Revenue
-AU$119.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Cost of Revenue
-AU$224.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
Sonic Healthcare Ltd
Glance View
Sonic Healthcare Ltd. is a global leader in the provision of laboratory medicine and diagnostic services, successfully weaving its way into the fabric of healthcare across diverse markets. Founded in Australia in 1987, the company has expanded its operations internationally, boasting a network that spans Europe, North America, Asia, and New Zealand. Sonic's core business involves pathology and radiology services, which cater to hospitals, general practices, and patients, ensuring accurate and timely diagnoses. With a keen focus on innovation, Sonic integrates advanced technology and artificial intelligence into its processes, enhancing the quality and efficiency of its services, while also adhering to stringent regulatory standards. This commitment to excellence has positioned Sonic as a trusted partner in the healthcare ecosystem, crucial for both patient outcomes and the smooth functioning of healthcare systems. Investors looking at Sonic Healthcare will appreciate the company's resilient growth trajectory and prudent operational strategy. The company's revenue stream is underpinned by long-term contracts with healthcare providers and government entities, providing a stable and predictable cash flow. Sonic has demonstrated a history of profitability, underpinned by strategic acquisitions that bolster its market share and capabilities. Furthermore, the company's significant investment in research and development not only drives technological advancements but also aligns with evolving healthcare needs. As the global demand for diagnostic services continues to rise, driven by factors like an aging population and increased emphasis on preventive care, Sonic Healthcare presents a compelling investment opportunity for those seeking exposure to the robust and essential healthcare sector.
See Also
What is Sonic Healthcare Ltd's Cost of Revenue?
Cost of Revenue
-1.5B
AUD
Based on the financial report for Jun 30, 2024, Sonic Healthcare Ltd's Cost of Revenue amounts to -1.5B AUD.
What is Sonic Healthcare Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-9%
Over the last year, the Cost of Revenue growth was -13%. The average annual Cost of Revenue growth rates for Sonic Healthcare Ltd have been 4% over the past three years , -8% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
